Differential Myocardial Gene Delivery by Recombinant Serotype-Specific Adeno-associated Viral Vectors
Open Access
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (3) , 604-608
- https://doi.org/10.1016/j.ymthe.2004.06.110
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Identification of PDGFR as a receptor for AAV-5 transductionNature Medicine, 2003
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad SpecificityJournal of Virology, 2002
- Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage SpecificityJournal of Virology, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001
- Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and InfarctionNew England Journal of Medicine, 2000
- The Green Fluorescent Protein is an Efficient Biological Marker for Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3Virology, 1996
- Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian CellsPublished by Springer Nature ,1992